In the current pandemic, science has never been more highly scrutinised. Register for the EMWA symposium to find out how medical writers/communicators can uphold the integrity of scientific research. Open to non members. #EMWA50 #MedicalWriting #Symposium virtualconference.emwa.org/symposium-prog…

Bristol Myers Squibb's Zeposia boosts remission rates over placebo in ulcerative colitis patients bit.ly/3lEY7qy

Regeneron CEO: Trump ‘is a case of one’ and ‘weakest evidence’ for Covid-19 treatment politi.co/33Qr0tT

Novo Nordisk tees up phase 3 trial for once-weekly insulin bit.ly/2SM9CAb

Johnson & Johnson Pauses Vaccine Trial After ‘Unexplained Illness’ Strikes Participant bit.ly/34U4e3x

"If you want to invest in the mental health of people around the world, making us all more resilient to future crises, what can you do? Believe it or not, your best bet might be to fund drug development for psychedelic-assisted mental health treatments." vox.com/future-perfect…

Eli Lilly Pauses Covid-19 Antibody Treatment Trial Over Safety Concerns bit.ly/3jZdgTi

FDA Discovers Quality Control Problems At Eli Lilly Plant Manufacturing Potential COVID-19 Drug bit.ly/37444tn

3 Covid-19 vaccine trials were paused: Is that bad? bit.ly/31abLu5

Roche hit by 'high-end' biosimilar attack as Ocrevus, Tecentriq bounce back from COVID-19 slowdown bit.ly/2H3x0XM

Roche drops $500M into new global operations hub, with 500 jobs to follow bit.ly/34fzk6B

Here's how Bristol Myers' CEO Giovanni Caforio completed a $13B buyout: He moved fast, upped the bid quickly and demanded everyone to keep up - bit.ly/37sR7cS

Brain imaging biomarker may help predict treatment response in patients with psychiatric disorders, study reveals bit.ly/34hhHni

First COPD patient treated with RejuvenAir System in a multicenter clinical trial bit.ly/3m1YDPC

Scientists are beginning to understand that they have a social obligation to communicate their results in a way that benefits society...or at least they were in 1953, says @CWSNC2NYC at #ISMPP17AM. I hope we have made some progress since then, but there is plenty more still to do

DYK that 34% of patients said that social media would their medication taking and 40% said it would affect how they coped with chronic illness? @CWSNC2NYC at #ISMPP17AM citing Martin Delahunty in Official_EMWA journal Medical Writing. journal.emwa.org/social-media/s…

How do you measure reach, engagement and impact for journal articles and congress presentations? This #ISMPP17AM poster presents a semi-automated tool from Will Gattrell of @IpsenGroup, Heather Lang and @TomRees_MedComm View the poster at ismppposterhub.org/ismpp2021am/43

One of our #ISMPP17AM posters assesses current trends in pharma-affiliated preprints. It finds that only a small proportion of preprints published on medRxiv had authors affiliated with a pharmaceutical company. View the poster at ismppposterhub.org/ismpp2021am/25

A great film that anyone with an interest in #MS and #PatientExperience should watch. Personal stories are the most impactful, and this one triggers so many emotions. We are very proud that Oxford PharmaGenesis has been able to support such an important project.

Developing #PLSPs plain language summaries of publications that are easy to understand strengthens communications with #patients & the public. Hear from industry professionals from Oxford PharmaGenesis Future Science Group Daiichi Sankyo Bayer AG Register here: ow.ly/pBxn50EqM7E